CLINICAL_TRIALS
trial_result
· 2012-03-08
Clinical Trial Update: Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles [Phase 3]
Summary
Phase 3 trial evaluating NT 201 for the treatment of lateral periorbital wrinkles has completed, assessing its efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz Pharmaceuticals GmbH | Conditions: Lateral Periorbital Wrinkles | Phase 3 | Status: COMPLETED